
About Spansules Pharmatech
Spansules Pharmatech is a Healthcare company based in Hyderabad (India). It operates as an a WHO GMP and ISO 9001:2008 certified manufacturer and exporter of pharmaceutical pellets. It operates on a B2B model. The company has 52 employees. Its Indian entity Spansules Pharmatech Private Limited reported revenue of βΉ73.76 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Pellet Production. Its competitors include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Spansules Pharmatech a who gmp and iso 9001:2008 certified manufacturer and exporter of pharmaceutical pellets, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and pellet production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Hyderabad, India
- Employees 52
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website spansulespharma.net
- Legal Name Spansules Pharmatech Private Limited
- Date of Incorporation 09 Oct, 2000
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹73.76 Cr
FY 2025 · -4% YoY
- Net Profit₹1.73 Cr
FY 2025 · 2% margin
- EBITDA₹8.06 Cr
FY 2025 · 11% margin
- Employee Count52
Associated legal entities of Spansules Pharmatech
Spansules Pharmatech operates through Spansules Pharmatech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Spansules Pharmatech Private Limited CIN U24230TG2000PTC035421 | Active | 09 Oct 2000 | Hyderabad, Telangana | ₹73.8 Cr | 52 | 4 | View details |
Board of directors of Spansules Pharmatech Private Limited (Spansules Pharmatech)
Spansules Pharmatech Private Limited is the primary company behind Spansules Pharmatech. The board of Spansules Pharmatech Private Limited currently have 4 directors; the longest-serving is Rama Devi Guttikonda, appointed in 2000.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rama Devi Guttikonda DIN 02019526 | Director | 09 Oct 2000 | 26 yrs | Spansules Pharmatech Private Limited |
| Venkata Subba Rao Guttikonda DIN 01900749 | Managing Director | 09 Oct 2000 | 26 yrs | Spansules Pharmatech Private Limited |
| Haswanth Rao Guttikonda DIN 06368794 | Director | 07 Feb 2020 | 6 yrs 8 mo | Spansules Pharmatech Private Limited |
| Harika Rao Guttikonda DIN 07585257 | Director | 07 Feb 2020 | 6 yrs 8 mo | Spansules Pharmatech Private Limited |
Financials of Spansules Pharmatech
Figures of Spansules Pharmatech Private Limited, the primary company behind Spansules Pharmatech, for FY 2025. Revenue was ₹73.76 Cr (-4% year on year). Net profit was ₹1.73 Cr (2% margin). EBITDA was ₹8.06 Cr (11% margin). Revenue has grown at a compounded annual rate of -2% over three years and +5% over five years.
- ₹73.76 CrRevenue · FY 2025 · -4% YoY
- ₹1.73 CrNet profit · 2% margin
- ₹8.06 CrEBITDA · 11% margin
- ₹5.00 CrPaid-up capital
- 52Employees (provident fund records)
- -2%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Spansules Pharmatech Private Limited are on its company page.
Detailed financial statements for Spansules Pharmatech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Spansules Pharmatech
Spansules Pharmatech has 10 listed competitors in our database, 4 of them funded. They include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | – | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. |
Detailed competitors of Spansules Pharmatech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Spansules Pharmatech
The website of Spansules Pharmatech (spansulespharma.net) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 69.7% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Spansules Pharmatech (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spansules Pharmatech
Spansules Pharmatech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Spansules Pharmatech has 52 employees.
The primary company behind Spansules Pharmatech, Spansules Pharmatech Private Limited, reported revenue of βΉ73.76 Cr for FY 2025, down 4% year on year.
Spansules Pharmatech a who gmp and iso 9001:2008 certified manufacturer and exporter of pharmaceutical pellets, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and pellet production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Spansules Pharmatech's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Spansules Pharmatech operates through Spansules Pharmatech Private Limited.
The legal entities of Spansules Pharmatech currently have 4 directors, including Rama Devi Guttikonda, Haswanth Rao Guttikonda, Harika Rao Guttikonda and others.